Coldstream Capital Management’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,588	Closed	-$53.3K	–	1618
2025 Q1	$53.3K	Buy	+1,588	New	+$53.3K	﹤0.01%	1676